Authors/Disclosures
|
Kiyokazu Kawabe, MD
(Department of Neurology Saiseikai Yokohamashi Tobu Hospital)
|
No disclosure on file |
|
Yasuhiro Yoshii, MD, PhD
(Nippon-Koukan Hospital)
|
No disclosure on file |
|
Charles W. Gorodetzky, MD, PhD
(Consultant in Pharmaceutical Medicine)
|
No disclosure on file |
|
Osamu Kano, MD, PhD
(Department of Neurology, Toho University Faculty of Medicine)
|
Dr. Kano has nothing to disclose. |
|
Ken Ikeda, MD, PhD
(Toho University Omori Medical Center)
|
No disclosure on file |
|
Yasuo Iwasaki, MD
|
No disclosure on file |
|
Ralf Linker
(Uniklinik Erlangen)
|
Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen. |